|
1
|
Kirkali Z, Chan T, Manoharan M, Algaba F,
et al: Bladder cancer: epidemiology, staging and grading, and
diagnosis. Urology. 66:4–34. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lei AQ, Cheng L and Pan CX: Current
treatment of metastatic bladder cancer and future directions.
Expert Rev Anticancer Ther. 11:1851–1862. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Borriello A, Cucciolla V, Della Raqione F
and Galletti P: Dietary polyphenols: Focus on resveratrol, a
promising agent in the prevention of cardiovascular diseases and
control of glucose homeostasis. Nutr Metab Cardiovasc Dis.
20:618–625. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Albani D, Polito L and Forloni G: Sirtuins
as novel targets for Alzheimer’s disease and other
neurodegenerative disorders: experimental and genetic evidence. J
Alzheimers Dis. 19:11–26. 2010.
|
|
5
|
Harikumar KB and Aggarwal BB: Resveratrol:
a multitargeted agent for age-associated chronic diseases. Cell
Cycle. 7:1020–1035. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lin X, Wu G, Huo WQ, Zhang Y and Jin FS:
Resveratrol induces apoptosis associated with mitochondrial
dysfunction in bladder carcinoma cells. Int J Urol. 19:757–764.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bai Y, Mao QQ, Qin J, Zheng XY, Wang YB,
Yang K, Shen HF and Xie LP: Resveratrol induces apoptosis and cell
cycle arrest of human T24 bladder cancer cells in vitro and
inhibits tumor growth in vivo. Cancer Sci. 101:488–493. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bartel DP: MicroRNAs: genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Winter J, Jung S, Keller S, Gregory RI and
Diederich S: Many roads to maturity: microRNA biogenesis pathways
and their regulation. Nat Cell Biol. 11:228–234. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Si ML, Zhu S, Wu H, Lu Z, Wu F and Mo YY:
miR-21-mediated tumor growth. Oncogene. 26:2799–2803. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Link A, Becker V, Goel A, Wex T and
Malfertheiner P: Feasibility of fecal microRNAs as novel biomarkers
for pancreatic cancer. PLoS One. 7:e429332012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Buscaglia LE and Li Y: Apoptosis and the
target genes of microRNA-21. Chin J Cancer. 30:371–380. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tili E, Michaille JJ, Alder H, Volinia S,
Delmas D, Latruffe N and Croce CM: Resveratrol modulates the levels
of microRNAs targeting genes encoding tumor-suppressors and
effectors of TGFβ signaling pathway in SW480 cells. Biochem
Pharmacol. 80:2057–2065. 2010.PubMed/NCBI
|
|
14
|
Liu P, Liang H, Xia Q, Li P, Kong H, Lei
P, Wang S and Tu Z: Resveratrol induces apoptosis of pancreatic
cancers cells by inhibiting miR-21 regulation of BCL-2 expression.
Clin Transl Oncol. 15:741–746. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tao J, Lu Q, Wu D, Li P, Xu B, Qing W,
Wang M, Zhang Z and Zhang W: microRNA-21 modulates cell
proliferation and sensitivity to doxorubicin in bladder cancer
cells. Oncol Rep. 25:1721–1729. 2011.PubMed/NCBI
|
|
16
|
Ching CB and Hansel DE: Expanding
therapeutic targets in bladder cancer: the PI3K/Akt/mTOR pathway.
Lab Invest. 90:1406–1414. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Oka N, Tanimoto S, Taue R, Nakatsuji H,
Kishimoto T, Izaki H, Fukumori T, Takahashi M, Nishitani M and
Kanayama HO: Role of phosphatidylinositol-3 kinase/Akt pathway in
bladder cancer cell apoptosis induced by tumor necrosis
factor-related apoptosis-inducing ligand. Cancer Sci. 97:1093–1098.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Pietenpol JA, Paradopoulos N, Markowitz S,
Willson JK, Kinzler KW and Vogelstein B: Paradoxical inhibition of
solid tumor cell growth by bcl2. Cancer Res. 54:3714–3717.
1994.PubMed/NCBI
|
|
19
|
Kunze D, Wuttig D, Fuessel S, Kraemer K,
Kotzsch M, Meye A, Grimm MO, Hakenberg OW and Wirth MP: Multitarget
siRNA inhibition of antiapoptotic genes (XIAP, BCL2, BCL-XL) in
bladder cancer cells. Anticancer Res. 28:2259–2263. 2008.PubMed/NCBI
|
|
20
|
Riedl SJ and Shi Y: Molecular mechanisms
of caspase regulation during apoptosis. Nat Rev Mol Cell Biol.
5:897–907. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jung JI, Cho HJ, Kim J, Kwon DY and Park
JH: trans-10, cis-12 conjugated linoleic acid inhibits insulin-like
growth factor-I receptor signaling in TSU-Pr1 human bladder cancer
cells. J Med Food. 13:13–19. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Jang M, Cai L, Udeani GO, Slowing KV,
Thomas CF, Beecher CW, Fong HH, Farnsworth NR, Kinghorn AD, Mehta
RG, Moon RC, et al: Cancer chemopreventive activity of resveratrol,
a natural product derived from grapes. Science. 275:218–220. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Baur JA and Sinclair DA: Therapeutic
potential of resveratrol: the in vivo evidence. Nat Rev Drug
Discov. 5:493–506. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang YB, Qin J, Zheng XY, Bai Y, Yang K
and Xie LP: Diallyl trisulfide induces Bcl-2 and
caspase-3-dependent apoptosis via downregulation of Akt
phosphorylation in human T24 bladder cancer cells. Phytomedicine.
17:363–368. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Shahjee HM, Koch KR, Guo L, Zhang CO and
Keay SK: Antiproliferative factor decreases Akt phosphorylation and
alters gene expression via CKAP4 in T24 bladder carcinoma cells. J
Exp Clin Cancer Res. 29:1602010. View Article : Google Scholar : PubMed/NCBI
|
